|
US6479055B1
(en)
*
|
1993-06-07 |
2002-11-12 |
Trimeris, Inc. |
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
|
|
US6271198B1
(en)
|
1996-11-06 |
2001-08-07 |
Genentech, Inc. |
Constrained helical peptides and methods of making same
|
|
US6818740B1
(en)
|
1997-04-17 |
2004-11-16 |
Whitehead Institute For Biomedical Research |
Inhibitors of HIV membrane fusion
|
|
US6150088A
(en)
|
1997-04-17 |
2000-11-21 |
Whitehead Institute For Biomedical Research |
Core structure of gp41 from the HIV envelope glycoprotein
|
|
US6841657B2
(en)
|
1997-04-17 |
2005-01-11 |
Whitehead Institute For Biomedical Research |
Inhibitors of HIV membrane fusion
|
|
US6747126B1
(en)
|
1998-07-30 |
2004-06-08 |
Whitehead Institute For Biomedical Research |
Peptide inhibitors of HIV entry
|
|
US7960504B2
(en)
|
1998-07-30 |
2011-06-14 |
Whitehead Institute For Biomedical Research |
Inhibitors of HIV membrane fusion
|
|
WO2000066622A1
(en)
|
1999-05-05 |
2000-11-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T20/dp178 and t21/dp107 are activators of human phagocyte formyl peptide receptors
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
DE60037450T2
(de)
*
|
1999-12-16 |
2008-12-04 |
Whitehead Institute For Biomedical Research, Cambridge |
Fünf-helix protein
|
|
US6605427B2
(en)
|
2000-02-10 |
2003-08-12 |
Panacos Pharmaceuticals, Inc. |
Assay for detection of viral fusion inhibitors
|
|
WO2001070262A2
(en)
*
|
2000-03-17 |
2001-09-27 |
Panacos Pharmaceuticals, Inc. |
A method for generating immunogens that elicit neutralizing antibodies against fusion-active regions of hiv envelope proteins
|
|
US20050065319A1
(en)
*
|
2000-12-19 |
2005-03-24 |
Baroudy Bahige M. |
Combination method for treating viral infections
|
|
CN1255548C
(zh)
|
2001-06-15 |
2006-05-10 |
霍夫曼-拉罗奇有限公司 |
gp41片段的乙酰化
|
|
AU2003210659A1
(en)
*
|
2002-01-24 |
2003-09-02 |
Sangstat Medical Corporation |
Combination therapy for treatment of hiv infection
|
|
CN1327897C
(zh)
|
2002-09-24 |
2007-07-25 |
重庆前沿生物技术有限公司 |
Hiv感染的肽衍生物融合抑制剂
|
|
AU2003299085B2
(en)
*
|
2002-09-27 |
2008-04-10 |
Tanox, Inc. |
Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
|
|
US7556813B2
(en)
*
|
2002-09-27 |
2009-07-07 |
Trimeris, Inc. |
Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides
|
|
PT1583542E
(pt)
|
2003-01-14 |
2008-09-17 |
Gilead Sciences Inc |
Composições e métodos para terapia de combinação antiviral
|
|
SI1624891T2
(sl)
*
|
2003-05-06 |
2013-09-30 |
Biogen Idec Hemophilia Inc. |
Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije
|
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
US20050281829A1
(en)
*
|
2003-05-06 |
2005-12-22 |
Hehir Cristina A T |
Fc chimeric proteins with anti-HIV drugs
|
|
WO2004100882A2
(en)
*
|
2003-05-06 |
2004-11-25 |
Syntonix Pharmaceuticals, Inc. |
Inhibition of drug binding to serum albumin
|
|
US7348004B2
(en)
|
2003-05-06 |
2008-03-25 |
Syntonix Pharmaceuticals, Inc. |
Immunoglobulin chimeric monomer-dimer hybrids
|
|
EP1696943A4
(en)
*
|
2003-12-22 |
2007-09-19 |
Yeda Res & Dev |
PEPTIDES DIASTEREOMERS USEFUL AS INHIBITORS OF MEMBRANE PROTEIN ASSEMBLY
|
|
RU2006128593A
(ru)
*
|
2004-01-07 |
2008-02-20 |
Тримерис, Инк. (Us) |
Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека
|
|
EP1755667B1
(en)
|
2004-06-01 |
2013-07-17 |
Merck Sharp & Dohme Corp. |
Stable peptide mimetic of hiv gp41 fusion intermediate
|
|
US20060154895A1
(en)
*
|
2004-12-09 |
2006-07-13 |
Maxwell Gordon |
Method of treating acquired immunedeficiency syndrome
|
|
GB0501352D0
(en)
*
|
2005-01-21 |
2005-03-02 |
Slingsby Jason H |
Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
|
|
EP1868652A2
(en)
*
|
2005-04-05 |
2007-12-26 |
Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. |
Method for shielding functional sites or epitopes on proteins
|
|
ATE537183T1
(de)
|
2006-02-02 |
2011-12-15 |
Trimeris Inc |
Hiv-fusionshemmerpeptide mit verbesserten biologischen eigenschaften
|
|
EP1886696A1
(en)
*
|
2006-08-03 |
2008-02-13 |
Endotis Pharma |
Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
|
|
TW200817438A
(en)
|
2006-08-17 |
2008-04-16 |
Hoffmann La Roche |
A conjugate of an antibody against CCR5 and an antifusogenic peptide
|
|
AU2007286451A1
(en)
|
2006-08-17 |
2008-02-21 |
F. Hoffmann-La Roche Ag |
A conjugate of an antibody against CCR5 and an antifusogenic peptide
|
|
EP2114999A2
(en)
|
2006-12-12 |
2009-11-11 |
Biorexis Pharmaceutical Corporation |
Transferrin fusion protein libraries
|
|
CL2008000707A1
(es)
|
2007-03-13 |
2008-09-22 |
Hoffmann La Roche |
Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion.
|
|
CN101678125A
(zh)
*
|
2007-04-03 |
2010-03-24 |
特里梅里斯公司 |
用于递送抗病毒肽治疗剂的新制剂
|
|
AR067584A1
(es)
|
2007-07-20 |
2009-10-14 |
Hoffmann La Roche |
Un conjugado de un anticuerpo contra la cd4 y peptidos antifusogenicos
|
|
CA2700354A1
(en)
*
|
2007-09-25 |
2009-04-02 |
Trimeris, Inc. |
Novel methods of synthesis for therapeutic antiviral peptides
|
|
CA2797033C
(en)
|
2010-04-22 |
2021-10-19 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
|
CA2808675A1
(en)
|
2010-09-14 |
2012-03-22 |
F. Hoffmann-La Roche Ag |
Serpin-finger fusion polypeptide
|
|
TWI577377B
(zh)
|
2010-09-16 |
2017-04-11 |
Ｖｉｉｖ醫療保健公司 |
醫藥組合物
|
|
CN103974971B
(zh)
*
|
2012-02-28 |
2016-09-14 |
中国人民解放军军事医学科学院毒物药物研究所 |
用于抑制hiv的多肽、其药物组合物及其用途
|
|
WO2014145718A2
(en)
|
2013-03-15 |
2014-09-18 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
|
SG11201505926VA
(en)
|
2013-03-15 |
2015-09-29 |
Biogen Ma Inc |
Factor ix polypeptide formulations
|
|
WO2018002902A1
(en)
|
2016-07-01 |
2018-01-04 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Antibody-drug conjugates and therapeutic methods using the same
|